Refine by
Tissue Analysis Articles & Analysis
7 news found
These innovative products offer researchers a powerful tool to unravel the complexities of the immune system and accelerate the development of new therapies. Tissue microarray is a recent innovation in the field of pathology. This versatile technology for automated data analysis facilitates retrospective and prospective human tissue studies. It ...
CD BioSciences, a US-based biotechnology company focusing on the development of imaging technology, announced the launch of its new 3D Tissue Imaging Services to researchers with comprehensive solutions for 3D imaging of tissues, including 3D Immunolabeling, Tissue Removal, 3D Imaging, and Quantitative Image Analysis. ...
The Microplate Reader Company – and InvivoSciences, Inc. – a leader in stem cell tissue engineering providing a novel solution in first-in-class drug discovery – announced today a strategic collaboration to market the time-dependent fluorescent assessment of engineered 3D heart tissues using advanced microplate reader technologies. Employing ...
Its PROTAC in vivo evaluation services encompass general studies of toxicology and in vivo pharmacokinetics, tests of allergy and in vitro hemolysis, as well as immunotoxicology analysis. Scientists of BOC Sciences can fully elucidate drug toxicity by evaluating single administration, multiple administrations, dose range exploration, or maximum tolerance within animal models. ...
“Shoulder MRI scans are common in shoulder pain management healthcare, usually for soft tissue analysis,” said Ron Soferman, CEO at RSIP Vision. “Deep learning (DL) algorithms can be developed for accurate segmentation of the shoulder bones. ...
Reveal Surgical is working on changing that reality through its new, AI-based Sentry technology, which leverages a combination of AI and Raman spectroscopy to provide real-time tissue diagnostics during surgery for otherwise-invisible tumors. Raman spectroscopy is the use of light scattering from a laser to detect molecular structures and compositions of a material—in this ...
AVB-620 has completed a Phase Ib clinical trial assessing safety, pharmacokinetics, and fluorescence properties using tissue image analysis. A Phase II clinical trial for AVB-620 in breast cancer is ongoing. ...